These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 6164471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.
    Richie JP, Steele GD, Wilson RE, Ervin T, Wang BS, Mannick JA.
    J Urol; 1984 Feb; 131(2):236-8. PubMed ID: 6199519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The therapy of renal adenocarcinoma with immune RNA.
    deKernion JB, Ramming KP.
    Invest Urol; 1980 Mar; 17(5):378-81. PubMed ID: 7358501
    [Abstract] [Full Text] [Related]

  • 7. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
    Skinner DG, Dekernion JB, Brower PA, Ramming KP, Pilch YH.
    J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
    [Abstract] [Full Text] [Related]

  • 8. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA, Dekernion JB, Ramming KP.
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subcutaneous interleukin-2 in combination with vinblastine for metastatic renal cancer: cytolytic activity of peripheral blood lymphocytes.
    Indrová M, Bubeník J, Jakoubková J, Símová J, Jandlová T, Helmichová E, Benesová K, Hesová M, Stáhalová V.
    Neoplasma; 1994 Mar; 41(4):197-200. PubMed ID: 7935991
    [Abstract] [Full Text] [Related]

  • 11. Prevention of death from metastases by immune RNA therapy.
    Wang BS, Onikul SR, Mannick JA.
    Science; 1978 Oct 06; 202(4363):59-60. PubMed ID: 694519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
    Kern DH, Fritze D, Drogemuller CR, Pilch YH.
    J Natl Cancer Inst; 1976 Jul 06; 57(1):97-103. PubMed ID: 1003510
    [Abstract] [Full Text] [Related]

  • 14. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL.
    Cancer Res; 1993 Oct 15; 53(20):4745-9. PubMed ID: 8402652
    [Abstract] [Full Text] [Related]

  • 15. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
    Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ.
    N Engl J Med; 2000 Sep 14; 343(11):750-8. PubMed ID: 10984562
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of disseminated renal cell carcinoma with transfer factor.
    Montie JE, Bukowski RM, Deodhar SH, Hewlett JS, Stewart BH, Straffon RA.
    J Urol; 1977 May 14; 117(5):553-6. PubMed ID: 859196
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
    Märten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hübinger AM, Müller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt-Wolf IG.
    Hum Gene Ther; 2003 Mar 20; 14(5):483-94. PubMed ID: 12691613
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
    Watanabe MA, Almeida DO, Serrano SV, Sales VS, Soares FA, de Lucca FL.
    Cell Mol Biol (Noisy-le-grand); 1997 May 20; 43(3):393-8. PubMed ID: 9193794
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.